Metraipolis › archive › dc_5d645b8943fe

SHANK3 and beta-synuclein are novel blood-based biomarkers for the Phelan-McDermid Syndrome: a pilot study — Europe PMC PMID:41876457

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41876457
DOI
10.1038/s41398-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-11-04T01:19:48.857Z
SHA-256 of the archived text
d43f03c043e478e7d3e3123179443da5630312d6a82544de628a1e42f5fed2f3
Stable URL of this page
https://metraipolis.com/documento/dc_5d645b8943fe

How to cite

SHANK3 and beta-synuclein are novel blood-based biomarkers for the Phelan-McDermid Syndrome: a pilot study — Europe PMC PMID:41876457 — Europe PMC (en), https://europepmc.org/article/MED/41876457 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5d645b8943fe (Metraipolis archive dc_5d645b8943fe, sha256 d43f03c043e478e7d3e3123179443da5630312d6a82544de628a1e42f5fed2f3)
BibTeX
@misc{dc5d645b8943fe,
  title = {SHANK3 and beta-synuclein are novel blood-based biomarkers for the Phelan-McDermid Syndrome: a pilot study — Europe PMC PMID:41876457},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41876457},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5d645b8943fe; sha256 d43f03c043e478e7d3e3123179443da5630312d6a82544de628a1e42f5fed2f3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41876457. Agents can read the archived copy with the MCP tool read_document.